Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)

Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)

Scope of the Report

The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global bio CMO market has been forecasted for the years 2016-2021, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza, Boehringer Ingelheim, Samsung Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.

Company Coverage

Boehringer Ingelheim
Samsung Electronics (Samsung Biologics)

Executive Summary

Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. World’s largest pharmaceutical firms are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The global bio CMO market is supported by various growth drivers, such as increase in pharmaceutical industry, growth in use of biosimilars, potential biologics blockbusters, etc. Yet, the market faces certain challenges, such as risk associated with CMOs, presence of in-house manufacturing facilities of big pharma companies, productivity issues with mammalian cell system, etc.

1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry Overview
Table 1: History of Pharmaceutical Industry
2.1.1 Segments of Pharmaceutical Industry (Drugs)
Table 2: Pharmaceutical Industry Segments
2.2 Biotechnology/Biologics Overview
Table A: Chemical Drugs v/s 1st Generation Biologics v/s 2nd Generation Biologics
2.3 Biosimilar Overview
Table : US Approved Biosimilars
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview
3. Global Market Analysis
3.1 Global Biologics Market: An Analysis
3.1.1 Global Biologics Market by Value
Table 3: Global Biologics Market by Value; 2016-2021 (US$ Billion)
3.1.2 Global Biologics Market by Top Selling Drugs
Table C: Top Selling Biologics Drugs; 2014
3.1.3 Global Biologics Market by Product in Development
Table 4: Global Biologics Market by Products in Development; 2015-2016
3.1.4 Global Biologics Manufacturing market by Value
Table 5:Global Biologics Manufacturing Market by Value; 2012-2015 (US$ Billion)
Table 6: Global Biologics Manufacturing Market by Value; 2016-2020 (US$ Billion)
3.2 Global Bio CMO Market: An Analysis
3.2.1 Global Bio CMO Market by Penetration Rate
Table 7: Global Bio CMO Market by Penetration Rate; 2012-2015
Table 8: Global Bio CMO Market by Penetration Rate; 2016-2021
3.2.2 Global Bio CMO Market by Value
Table 9: Global Bio CMO Market by Value; 2012-2015 (US$ Billion)
Table 10: Global Bio CMO Market by Value; 2016-2020 (US$ Billion)
3.2.3 Global Bio CMO Market by Capacity
Table 11: Global Bio CMO Market by Capacity; 2014-2020 (KL)
3.2.4 Global Bio CMO Market by Segments
Table 12: Global Bio CMO Market by Segments; 2015
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Global Pharmaceutical Market Growth
Table 13: Global Pharmaceutical Industry by Value; 2012-2020 (US$ Billion)
4.1.2 Potential Biologics Blockbusters
Table D: Potential Biologics; 2016
4.1.3 Increase in Biosimilar Market
Table 14: Global Biosimilar Market; 2015-2020 (US$ Billion)
4.1.4 Preference of Biologics Over Small Molecules
Table 15: Global Biopharmaceuticals (Drugs) Market by Segments; 2006-2020
4.2 Challenges
4.2.1 Presence for In-House Biopharma Manufacturing
4.2.2 Risk Associated with CMOs
4.2.3 Productivity Issue with Mammalian Cell System
4.3 Market Trends
4.3.1 Big Pharmaceuticals Outsourcing Rate
Table 16: Big Pharmaceuticals Outsourcing Rate; 2015-2020
4.3.2 Capacity Utilization Rate of CMOs
Table 17: Capacity Utilization Rate of the Global CMO Industry; 2014-2020
4.3.3 Growth in Mammalian Cell Structure
4.3.4 Stringent Regulatory Requirements for Biologics and Biosimilars
5. Competitive Landscape
5.1 Global Bio CMO Market by Number of Firms
Table 18: Global Bio CMO Market by Number of Firms; 2015
5.2 Global Bio CMO Market Players by Capacity
Table 19: Global Bio CMO Players by Capacity; 3Q16 (KL)
6. Company Profiling
6.1 Lonza
6.1.1 Business Overview
6.1.2 Financial Overview
Table 20: Lonza Sales; 2011-2015 (US$ Billion)
Table 21: Lonza Sales by Segments; 2015
Table 22: Lonza Sales by Region; 2015
6.1.3 Business Strategy
6.2 Boehringer Ingelheim
6.2.1 Business Overview
6.2.2 Financial Overview
Table 23: Boehringer Ingelheim Sales; 2012-2015 (US$ Billion)
Table 24: Boehringer Ingelheim Sales by Segments; 2015
Table 25: Boehringer Ingelheim Sales by Region; 2015
6.2.3 Business Strategy
6.3 Samsung Electronics (Samsung Biologics)
6.3.1 Business Overview
Table 26: Samsung Electronics Segments Overview
Table 27: Samsung Electronics Ownership Structure
6.3.2 Financial Overview
Table 28: Samsung Electronics Revenue; 2011-2015
Table 29: Samsung Electronics Revenue by Segments; 2015
6.3.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook